Liver cancer is a frequent disease. Patients with liver cancer have most of the time an underlying chronic liver disease, often without knowing it since the liver is an organ which does not trigger pain. However, it is possible to cure patients from their liver cancer when the diagnosis is done at an early stage. Therefore diagnostic tools for detecting liver cancer are of utmost importance.
Therapeutically great progresses have been realized in the last years, patients have access to more possible treatments. But the treatment of patients with liver cancer is complex.
The Swiss Foundation against Liver Cancer aims at disseminating information about this disease to increase awareness and to support research to improve the diagnosis, therapy and management of patients and families confronted with this disease.
In a recent “Ask the Author” session, we had the pleasure of hosting Professor Vitale from the University of Padova, Italy. Renowned for his contributions to the field of hepatocellular carcinoma (HCC), Professor Vitale discussed his latest publication, “Merits and Boundaries of the BCLC Staging and Treatment Algorithm: Learning From the Past to Improve the
Prof. Jean-François Dufour co-organized the HCC Day 2024 related to Liver Cancer treatments end of February in Bern, Switzerland. In this short video summary, he briefly recaps the 6 lectures given by world-wide Key Opinion Leaders. If you are active in this medical field, it should be of high interest to you. All the videos
The HCC event in 2024 took place on the 29th of February in Bern as well as online. The videos of all the lectures can be found here
